Event Specialty: Bronchoscopy
For its fifth year running, Auris Health will participate at the AABIP Annual Conference in Nashville August 11 –13, 2022. Visit our booth, tech suite, or virtual booth to learn about robotic-assisted bronchoscopy with the MONARCH™ Platform.
Also, join us from 12pm –12:45pm CST for our sponsored talk with Stephen P. Kovacs, DO, FCCP, Chief, Division of Pulmonary Medicine and Co-Director of the UPMC Hamot Comprehensive Lung Center and Faisal Khan, MD, Medical Director, Interventional Pulmonology, Endoscopy, Respiratory and Pulmonary Rehabilitation Services at Franciscan Saint Francis Hospital as they present "Why I Chose MONARCH™: A Practical Discussion of Benefits in an RAB Procedure."
This event will serve as a forum to reviewand discuss the current concepts andrecent advances in interventional pulmonology and advanced pulmonary diagnostic procedures as well as showcase new technological advances and research innovations of interest to interventional pulmonologists, advanced diagnostic pulmonologists, critical care specialists, thoracic surgeons, advanced nurse practitioners, physician assistants, trainees, and other healthcare providers.Learn more about MONARCH
Bronchoscopy Important Safety Statement:
Complications from bronchoscopy are rare and most often minor, but if they occur, may include breathing difficulty, vocal cord spasm, hoarseness, slight fever, vomiting, dizziness, bronchial spasm, infection, low blood oxygen, bleeding from biopsied site, or an allergic reaction to medications. Only rarely do patients experience other more serious complications (for example, collapsed lung, respiratory failure, heart attack and/or cardiac arrhythmia).
Urology Important Safety Statement:
Adverse effects from both Mini-PCNL and Ureteroscopy include pain, urinary tract infection, fever, hematuria (presence of blood in urine), exposure to low levels of radiation, retained or residual stones.
Adverse effects from ureteroscopy may include pain, perforation or injury to the ureter, resulting in extravasation of fluid and urine (urinoma), stricture of the ureter with risk of subsequent obstruction (hydronephrosis needing further repair), rare avulsion of the ureter, urinary blood clots, residual stones.
PCNL access may result in minor and major adverse effects. Minor effects include fever and nephrostomy leak. Major adverse effects may include injuries to pleura, liver, spleen, large vessels with related bleeding, gallbladder, duodenum, jejunum, colon with related cutaneous fistula, fever, pain, ileus, elevated counts.
Major adverse effects related to stone removal may include infection and urosepsis, intravascular fluid overload, extravasation of fluid, and post percutaneous nephrolithotomy bleeding.